Premium
S2‐04–06: Safety, tolerability and immunogenicity of the Aβ immunotherapeutic vaccine CAD106 in a first‐in‐man study in Alzheimer patients
Author(s) -
Winblad Bengt
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.295
Subject(s) - tolerability , medicine , placebo , adverse effect , immunogenicity , cohort , surgery , anesthesia , immunology , antibody , pathology , alternative medicine